Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC on Rembrandt sale

This article was originally published in The Tan Sheet

Executive Summary

FTC is collecting public comment through Dec. 7 on the proposed divestiture of the Rembrandt toothpaste and tooth whitening business by Procter & Gamble and Gillette, the commission announces Nov. 8. The firms, who recently merged, submitted a petition to FTC requesting that the sale of the business be approved. P&G and Gillette announced the proposed sale of the brand to Johnson & Johnson's Personal Products Company in October after FTC required the business be divested in order to maintain competition in the industry (1"The Tan Sheet" Oct. 31, 2005, p. 7)...

You may also be interested in...



Rembrandt Purchase Brings Whitening Category To J&J

Johnson & Johnson gains entry into the tooth whitening segment with the purchase of Rembrandt oral care brand from Procter & Gamble's Gillette division

US High Court Punts On ‘Objective Falsity’ FCA Standard

Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.

AstraZeneca Cashes In Moderna Chips

The firms' messenger RNA alliance inked back on 2013 is still very much ongoing but AstraZeneca decided to sell its considerable stake in the high-profile biotech to help finance its own pipeline.

Topics

UsernamePublicRestriction

Register

ID1135947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel